Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 131

1.

Self-reactivity in the dimeric intravenous immunoglobulin fraction.

Schaub A, Wymann S, Heller M, Ghielmetti M, Beleznay Z, Stadler BM, Bolli R, Miescher S.

Ann N Y Acad Sci. 2007 Sep;1110:681-93.

PMID:
17911483
2.

Comparative analysis of antigen specificities in the monomeric and dimeric fractions of intravenous immunoglobulin.

Miescher SM, Schaub A, Ghielmetti M, Baumann M, Vogel M, Bolli R, Stadler B.

Ann N Y Acad Sci. 2005 Jun;1051:582-90.

PMID:
16126998
3.

Monomerization of dimeric IgG of intravenous immunoglobulin (IVIg) increases the antibody reactivity against intracellular antigens.

Wymann S, Ghielmetti M, Schaub A, Baumann MJ, Stadler BM, Bolli R, Miescher SM.

Mol Immunol. 2008 May;45(9):2621-8. doi: 10.1016/j.molimm.2007.12.020. Epub 2008 Feb 15.

PMID:
18280568
4.

Identification of target antigens of self-reactive IgG in intravenous immunoglobulin preparations.

Bussone G, Dib H, Dimitrov JD, Camoin L, Broussard C, Tamas N, Guillevin L, Kaveri SV, Mouthon L.

Proteomics. 2009 Apr;9(8):2253-62. doi: 10.1002/pmic.200800819.

PMID:
19296548
5.

Variable region-connected, dimeric fraction of intravenous immunoglobulin enriched in natural autoantibodies.

Vassilev TL, Bineva IL, Dietrich G, Kaveri SV, Kazatchkine MD.

J Autoimmun. 1995 Jun;8(3):405-13.

PMID:
7576001
6.

Dimeric IVIG contains natural anti-Siglec-9 autoantibodies and their anti-idiotypes.

Schaub A, von Gunten S, Vogel M, Wymann S, Rüegsegger M, Stadler BM, Spycher M, Simon HU, Miescher S.

Allergy. 2011 Aug;66(8):1030-7. doi: 10.1111/j.1398-9995.2011.02579.x. Epub 2011 Mar 9.

PMID:
21385183
8.

The autoreactivity of therapeutic intravenous immunoglobulin (IVIG) preparations depends on the fractionation methods used.

Djoumerska I, Tchorbanov A, Pashov A, Vassilev T.

Scand J Immunol. 2005 Apr;61(4):357-63.

9.

Monomeric and dimeric IgG fractions show differential reactivity against pathogen-derived antigens.

Wymann S, Zuercher AW, Schaub A, Bolli R, Stadler BM, Miescher SM.

Scand J Immunol. 2011 Jul;74(1):31-41. doi: 10.1111/j.1365-3083.2011.02537.x.

10.

Intravenous immunoglobulin preparations contain anti-Siglec-8 autoantibodies.

von Gunten S, Vogel M, Schaub A, Stadler BM, Miescher S, Crocker PR, Simon HU.

J Allergy Clin Immunol. 2007 Apr;119(4):1005-11. Epub 2007 Mar 2.

PMID:
17337295
11.

Anti-idiotypes to oxidized LDL antibodies in intravenous immunoglobulin preparations--possible immunomodulation of atherosclerosis.

Wu R, Shoenfeld Y, Sherer Y, Patnaik M, Matsuura E, Gilburd B, Koike T, Peter JB.

Autoimmunity. 2003 Mar;36(2):91-7.

PMID:
12820691
12.

A close look at human IgG sialylation and subclass distribution after lectin fractionation.

Stadlmann J, Weber A, Pabst M, Anderle H, Kunert R, Ehrlich HJ, Peter Schwarz H, Altmann F.

Proteomics. 2009 Sep;9(17):4143-53. doi: 10.1002/pmic.200800931.

PMID:
19688751
13.

Analysis and functional consequences of increased Fab-sialylation of intravenous immunoglobulin (IVIG) after lectin fractionation.

Käsermann F, Boerema DJ, Rüegsegger M, Hofmann A, Wymann S, Zuercher AW, Miescher S.

PLoS One. 2012;7(6):e37243. doi: 10.1371/journal.pone.0037243. Epub 2012 Jun 4.

14.

Reducing sample complexity of polyclonal human autoantibodies by chromatofocusing.

Hagemann S, Faude A, Rabenstein M, Balzer-Geldsetzer M, Nölker C, Bacher M, Dodel R.

J Chromatogr B Analyt Technol Biomed Life Sci. 2010 Aug 15;878(24):2249-54. doi: 10.1016/j.jchromb.2010.06.039. Epub 2010 Jul 3.

PMID:
20655814
15.

Serum IgM, IgG and IgA block by F(ab')-dependent mechanism the binding of natural IgG autoantibodies from therapeutic immunoglobulin preparations to self-antigens.

Djoumerska IK, Tchorbanov AI, Donkova-Petrini VD, Pashov AD, Vassilev TL.

Eur J Haematol. 2005 Feb;74(2):101-10.

PMID:
15654899
16.

A disease-specific fraction isolated from IVIG is essential for the immunosuppressive effect of IVIG in experimental autoimmune myasthenia gravis.

Fuchs S, Feferman T, Meidler R, Margalit R, Sicsic C, Wang N, Zhu KY, Brenner T, Laub O, Souroujon MC.

J Neuroimmunol. 2008 Feb;194(1-2):89-96. doi: 10.1016/j.jneuroim.2007.11.020. Epub 2008 Feb 21.

PMID:
18178258
17.

What is the contents of the magic draft IVIg?

Seite JF, Shoenfeld Y, Youinou P, Hillion S.

Autoimmun Rev. 2008 Jun;7(6):435-9. doi: 10.1016/j.autrev.2008.04.012. Epub 2008 May 2. Review.

PMID:
18558358
18.
19.

Soluble CD4 antigen reactivity in intravenous immunoglobulin preparations: is it specific?

Perosa F, Rizzi R, Pulpito V, Dammacco F.

Clin Exp Immunol. 1995 Jan;99(1):16-20.

20.

Polyreactive autoantibodies purified from human intravenous immunoglobulins prevent the development of experimental autoimmune diseases.

Bruley-Rosset M, Mouthon L, Chanseaud Y, Dhainaut F, Lirochon J, Bourel D.

Lab Invest. 2003 Jul;83(7):1013-23.

PMID:
12861041

Supplemental Content

Support Center